Citations

Showing 10 of 108094 citations.

Impact of Ischemia Duration on Lower Limb Salvage in Combat Casualties
Perkins, Zane , Kersey, Alexander J., White, Joseph M., Lauria, Alexis L. , Propper, Brandon W., Tai, Nigel , Rasmussen, Todd E.

Mayo Clinic

Annals of Surgery | June 27, 2022 | Volume: 276 | Issue: 3 | Pages: 532-538

10.1097/sla.0000000000005560 | PMID 35972512 Get It

Introduction: The 6-hour threshold to revascularization of an ischemic limb is ubiquitous in the trauma literature, however, contemporary evidence suggests that this threshold should be less. This study aims to characterize the relationship between the duration of limb ischemia and successful limb salvage following lower extremity arterial trauma. Methods: This is a cohort study of the United States and UK military service members injured while serving in Iraq or Afghanistan between 2003 and 2013. Consecutive patients who sustained iliac, femoral, or popliteal artery injuries, and underwent surgery to attempt revascularization, were included. The association between limb outcome and the duration of limb ischemia was assessed using the Kaplan-Meier method. Results: One hundred twenty-two patients (129 limbs) who sustained iliac (2.3%), femoral (56.6%), and popliteal (41.1%) arterial injuries were included. Overall, 87 limbs (67.4%) were successfully salvaged. The probability of limb salvage was 86.0% when ischemia was ≤1 hour; 68.3% when between 1 and 3 hours; 56.3% when between 3 and 6 hours; and 6.7% when >6 hours ( P <0.0001). Shock more than doubled the risk of failed limb salvage [hazard ratio=2.42 (95% confidence interval: 1.27–4.62)]. Conclusions: Limb salvage is critically dependent on the duration of ischemia with a 10% reduction in the probability of successful limb salvage for every hour delay to revascularization. The presence of shock significantly worsens this relationship. Military trauma systems should prioritize rapid hemorrhage control and early limb revascularization within 1 hour of injury.
Toward harmonization of strategies for investigating lucidity in AD/ADRD: A preliminary research framework
Kolanowski, Ann , Gilmore‐Bykovskyi, Andrea L , Griffin, Joan M. , Mueller, Kimberly Diggle , Parnia, Sam

Mayo Clinic

Alzheimer's & Dementia | June 27, 2022 | Volume: 19 | Issue: 1 | Pages: 343-352

10.1002/alz.12709 | PMID 35757902 Get It

AbstractEpisodes of lucidity (ELs) in Alzheimer's disease and Alzheimer's disease‐related dementias (AD/ADRD), have garnered increasing attention as an important area of research. Efforts to study lucidity suffer from a lack of clear definitional criteria, inconsistent conceptualization, and diverse approaches to operationalizing features of these events. To advance systematic investigation of ELs in AD/ADRD, there is a need for clarity and precision in labeling event attributes, markers, and specific measurement strategies that enable operational harmonization across distinct approaches to investigating the relatively broad and nascent phenomenon. To that end, we propose a preliminary research framework to guide harmonization of approaches to investigating ELs in AD/ADRD. Our goal is to provide an initial schematic that encourages uniform labeling of operational decisions about ELs.
Ulcerative Wound in a Patient with Ulcerative Colitis
Fogwe, Delvise T. , Tawileh, Raya Abu, Aditya, Shah

Mayo Clinic

No container title available | June 27, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.165631150.07318544/v1 Get It

A minimum SNR criterion for computed tomography object detection in the projection domain
Hsieh, Scott S. , Yu, Lifeng , Huber, Nathan R. , Leng, Shuai , Yu, Lifeng , McCollough, Cynthia H.

Mayo Clinic

Medical Physics | June 27, 2022 | Volume: 49 | Issue: 8 | Pages: 4988-4998

10.1002/mp.15832 | PMID 35754205 Get It

Abstract Background A common rule of thumb for object detection is the Rose criterion, which states that a signal must be five standard deviations above background to be detectable to a human observer. The validity of the Rose criterion in CT imaging is limited due to the presence of correlated noise. Recent reconstruction and denoising methodologies are also able to restore apparent image quality in very noisy conditions, and the ultimate limits of these methodologies are not yet known. Purpose To establish a lower bound on the minimum achievable signal‐to‐noise ratio (SNR) for object detection, below which detection performance is poor regardless of reconstruction or denoising methodology. Methods We consider a numerical observer that operates on projection data and has perfect knowledge of the background and the objects to be detected, and determine the minimum projection SNR that is necessary to achieve predetermined lesion‐level sensitivity and case‐level specificity targets. We define a set of discrete signal objects that encompasses any lesion of interest and could include lesions of different sizes, shapes, and locations. The task is to determine which object of is present, or to state the null hypothesis that no object is present. We constrain each object in to have equivalent projection SNR and use Monte Carlo methods to calculate the required projection SNR necessary. Because our calculations are performed in projection space, they impose an upper limit on the performance possible from reconstructed images. We chose to be a collection of elliptical or circular low contrast metastases and simulated detection of these objects in a parallel beam system with Gaussian statistics. Unless otherwise stated, we assume a target of 80% lesion‐level sensitivity and 80% case‐level specificity and a search field of view that is 6 cm by 6 cm by 10 slices. Results When contains only a single object, our problem is equivalent to two‐alternative forced choice (2AFC) and the required projection SNR is 1.7. When consists of circular 6‐mm lesions at different locations in space, the required projection SNR is 5.1. When is extended to include ellipses and circles of different sizes, the required projection SNR increases to 5.3. The required SNR increases if the sensitivity target, specificity target, or search field of view increases. Conclusions Even with perfect knowledge of the background and target objects, the ideal observer still requires an SNR of approximately 5. This is a lower bound on the SNR that would be required in real conditions, where the background and target objects are not known perfectly. Algorithms that denoise lesions with less than 5 projection SNR, regardless of the denoising methodology, are expected to show vanishing effects or false positive lesions.
Clinical Images: Rice bodies in subacromial bursa at initial presentation of rheumatoid arthritis
Keshavamurthy, Chandana , Bansal, Pankaj , Bansal, Pankaj

Mayo Clinic

ACR Open Rheumatology | June 26, 2022 | Volume: 4 | Issue: 9 | Pages: 802-803

10.1002/acr2.11473 | PMID 35753696 Get It

What is Hepatology looking for version 2.0?
Malhi, Harmeet , Gores, Gregory J. , Gores, Gregory J. , Malhi, Harmeet

Mayo Clinic

Hepatology | June 26, 2022 | Volume: 77 | Issue: 3 | Pages: 707-708

10.1002/hep.32637 | PMID 35753067 Get It

Cathepsin B p.Gly284Val Variant in Parkinson’s Disease Pathogenesis
Milanowski, Łukasz , Hou, Xu , Bredenberg, Jenny M., Fiesel, Fabienne C. , Cocker, Liam T. , Soto‐Beasley, Alexandra I. , Walton, Ronald L., Strongosky, Audrey , Faroqi, Ayman H. , Boczarska‐Jedynak, Magdalena , Dulski, Jarosław , Fedoryshyn, Lyuda, Janik, Piotr , Karpinsky, Katherine, Krygowska‐Wajs, Anna, Lynch, Timothy , Olszewska, Diana A. , Opala, Grzegorz, Pulyk, O. R. , Sanotsky, Yanosh, Siuda, Joanna , Widlak, Mariusz, Rudzińska, Monika , Uitti, Ryan J. , Figura, Monika , Rzońca, Sylwia , Podgorska, Elzbieta , McLean, Pamela J. , Koziorowski, Dariusz , Ross, Owen A. , Hoffman‐Zacharska, Dorota , Springer, Wolfdieter , Wszołek, Zbigniew K. , Milanowski, Łukasz M , Strongosky, Audrey J, Dulski, Jaroslaw , Siuda, Joanna S. , Rudzinska-Bar, Monika , Uitti, Ryan, Rzonca-Niewczas, Sylwia , Podgorska, Elzbieta , Koziorowski, Dariusz , Hoffman-Zacharska, Dorota , Springer, Wolfdieter , Wszolek, Z.K. , Ross, Owen A , Fiesel, Fabienne C , Olszewska, Diana A , Hou, Xu , Beasley, Alexandra I , McLean, Pamela J , Barcikowska, Maria , Potulska‐Chromik, Anna , Rektorová, Irena , Sławek, Jarosław , Szlufik, Stanisław

Mayo Clinic

International Journal of Molecular Sciences | June 26, 2022 | Volume: 23 | Issue: 13 | Pages: 7086

10.3390/ijms23137086 | PMID 35806091 Get It

Parkinson’s disease (PD) is generally considered a sporadic disorder, but a strong genetic background is often found. The aim of this study was to identify the underlying genetic cause of PD in two affected siblings and to subsequently assess the role of mutations in Cathepsin B (CTSB) in susceptibility to PD. A typical PD family was identified and whole-exome sequencing was performed in two affected siblings. Variants of interest were validated using Sanger sequencing. CTSB p.Gly284Val was genotyped in 2077 PD patients and 615 unrelated healthy controls from the Czech Republic, Ireland, Poland, Ukraine, and the USA. The gene burden analysis was conducted for the CTSB gene in an additional 769 PD probands from Mayo Clinic Florida familial PD cohort. CTSB expression and activity in patient-derived fibroblasts and controls were evaluated by qRT-PCR, western blot, immunocytochemistry, and enzymatic assay. The CTSB p.Gly284Val candidate variant was only identified in affected family members. Functional analysis of CTSB patient-derived fibroblasts under basal conditions did not reveal overt changes in endogenous expression, subcellular localization, or enzymatic activity in the heterozygous carrier of the CTSB variant. The identification of the CTSB p.Gly284Val may support the hypothesis that the CTSB locus harbors variants with differing penetrance that can determine the disease risk.
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives
Sener, Uğur , Ruff, Michael W. , Campian, Jian , Sener, Ugur

Mayo Clinic

International Journal of Molecular Sciences | June 26, 2022 | Volume: 23 | Issue: 13 | Pages: 7046

10.3390/ijms23137046 | PMID 35806051 Get It

Glioblastoma (GBM) is the most common malignant brain tumor. Despite multimodality treatment with surgical resection, radiation therapy, chemotherapy, and tumor treating fields, recurrence is universal, median observed survival is low at 8 months and 5-year overall survival is poor at 7%. Immunotherapy aims to generate a tumor-specific immune response to selectively eliminate tumor cells. In treatment of GBM, immunotherapy approaches including use of checkpoint inhibitors, chimeric antigen receptor (CAR) T-Cell therapy, vaccine-based approaches, viral vector therapies, and cytokine-based treatment has been studied. While there have been no major breakthroughs to date and broad implementation of immunotherapy for GBM remains elusive, multiple studies are underway. In this review, we discuss immunotherapy approaches to GBM with an emphasis on molecularly informed approaches.
Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1–Associated Insulinoma
Sada, Alaa , Thompson, Geoffrey B. , Lyden, Melanie L. , Foster, Trenton R. , Dy, Benzon M. , McKenzie, Travis J. , Szabo Yamashita, Thomas, Habermann, Elizabeth B. , Yamashita, Thomas Szabo , Hálfdánarson, Þorvarður R. , Vella, Adrian

Mayo Clinic

Journal of the American College of Surgeons | June 26, 2022 | Volume: 235 | Issue: 5 | Pages: 756-763

10.1097/xcs.0000000000000307 | PMID 35752874 Get It

BACKGROUND: The differences between sporadic and multiple endocrine neoplasia type 1 (MEN-1)–associated insulinoma are not well described. Herein, we compared demographics, neoplasm characteristics, presentation, and survival in patients with sporadic vs MEN-1 insulinomas including benign and malignant disease. STUDY DESIGN: A retrospective study identified insulinoma patients. MEN-1 was defined based on genetic testing or clinically in patients with 2 or more primary MEN-1 tumor types. RESULTS: A total of 311 patients were identified: 84% benign and 16% malignant. The incidence of malignancy was similar (18% vs 16%, MEN-1 vs sporadic, p = 0.76). Within malignant patients, the median (interquartile range) age was 33 (25 ,44) years in MEN-1 vs 54 (41, 70) years in sporadic insulinoma (p = 0.04). There was no difference in sex or tumor size between MEN-1 and sporadic malignant insulinoma (p > 0.05). Of the 260 patients with benign insulinoma, 7% had MEN-1 syndrome. MEN-1 patients presented with insulinoma at a younger age: median (interquartile range) age was 38 (24, 49) years vs 52 (43, 65) years (p < 0.01). Resection of benign insulinoma was performed in 78% of the MEN-1 and 94% of the sporadic group (p = 0.03). Resected benign tumors were larger in the MEN-1 group: 2.0 (1.65, 2.45) cm vs 1.5 (1.2, 2.0) cm, respectively (p = 0.03). Concurrent insulinomas were more common in MEN-1 (17% vs 2%; p < 0.01). CONCLUSIONS: MEN-1 patients present with insulinoma at younger age and have larger benign pancreatic lesions at the time of resection compared with sporadic neoplasms. Younger patients and those with multifocal pancreatic neuroendocrine tumor in the setting of endogenous hyperinsulinism should be evaluated for MEN-1.
PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORETINAL LYMPHOMA
Soussain, C., Grommes, C., Ward, R., Peterson, C., Cravets, M., Mathias, A., Sosa, J., Kirby, B., Ding, Zhenduo, Yusuf, Issa Radwan , Rose, M., Steinberg, M., Tun, H., Soussain, Carole , Grommes, Christian , Cravets, Matt

Mayo Clinic

HemaSphere | June 25, 2022 | Volume: 6 | Issue: No issue available | Pages: 1967-1968

10.1097/01.hs9.0000851216.47783.78 Get It